A class of drugs commonly used to treat type 2 diabetes may double the risk of heart failure, according to a new analysis by researchers at Wake Forest University School of Medicine and colleagues.
The first study to look at sexual function in very long-term female survivors of genital-tract cancer found that these women were pleased with the quality of their cancer care but less satisfied with the emotional support and information they received about dealing with the effects of the disease and treatment on sexuality.
Acute spinal cord injury can damage spinal cord tissue and result in loss of functions such as mobility or feeling.
An improved approach to gene therapy may one day treat some of the nearly 200 inherited forms of blindness, scientists at Washington University School of Medicine in St. Louis suggest this week.
According to a new study published in The Journal of Sexual Medicine, sexual sensation in circumcised and uncircumcised men may not be so different after all.
More cases of venous thromboembolism are diagnosed in the three months following hospitalization than during hospitalization, but less than half of inpatients receive medications to prevent blood clots from occurring, according to a report in the July 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A rise in breast cancer incidence from the 1980s through 2001 paralleled trends in mammography screening and hormone therapy use, while a recent decline in incidence was consistent with a drop in hormone therapy use, according to a study of a large group of women enrolled in a single health plan,.
Health Canada is advising consumers not to use Liviro3, a natural health product marketed for sexual enhancement, due to concerns about possible side-effects. The product is not authorized for sale in Canada and has not been found in the Canadian marketplace, but is for sale on the Internet, and may have been brought into the country by travellers.
Health Minister George Abbott opened newly renovated areas of the BC Cancer Agency?s Fraser Valley Centre today, where approximately $12.5 million in funding has provided new radiation therapy equipment and increased chemotherapy capacity to improve patient care.
High-risk patients with hypertrophic cardiomyopathy appear to have reduced risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders, according to a study in the July 25 issue of JAMA.